Investments
2Portfolio Exits
1Latest Efrem Kamen News
Feb 26, 2022
Wilshire Lane Capital (“WLC”) today announced it has received $40 Million in LP commitments with the first close of its debut fund. New investors in the first close include J.P. Morgan Asset Management, Nile Capital Group, Schusterman Family Investments, TRB Advisors, First Close Partners, Asland Capital Partners, Bullock Capital and Efrem Kamen, founder of Pura […] The post Wilshire Lane Capital Launches New Fund to Invest in the Rapidly Growing PropTech Space appeared first on CRETECH.
Efrem Kamen Investments
2 Investments
Efrem Kamen has made 2 investments. Their latest investment was in ATAI Life Sciences as part of their Convertible Note on April 4, 2020.
Efrem Kamen Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
4/23/2020 | Convertible Note | ATAI Life Sciences | $24M | No | 2 | |
3/27/2019 | Series B |
Date | 4/23/2020 | 3/27/2019 |
|---|---|---|
Round | Convertible Note | Series B |
Company | ATAI Life Sciences | |
Amount | $24M | |
New? | No | |
Co-Investors | ||
Sources | 2 |
Efrem Kamen Portfolio Exits
1 Portfolio Exit
Efrem Kamen has 1 portfolio exit. Their latest portfolio exit was ATAI Life Sciences on June 18, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
6/18/2021 | IPO | 17 |
Date | 6/18/2021 |
|---|---|
Exit | IPO |
Companies | |
Valuation | |
Acquirer | |
Sources | 17 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.